Literature DB >> 6369977

Immunoglobulin G (IgG) subclasses and human disease.

V A Oxelius.   

Abstract

The isotypes of IgG, IgG1, IgG2, IgG3, and IgG4 were determined in immunoglobulin preparations and the effect on serum levels of treated patients. Serum IgG subclass deficiencies were recorded in different patient groups: (1) IgG2-IgG4 deficiency was associated with IgA deficiency. (2) IgG2-IgG4 deficiency was found in patients with ataxia telangiectasia. (3) Low IgG2 levels were recorded in patients with SLE; one of these patients with recurrent pericarditis was treated with immunoglobulin with good results. (4) Low IgG2 and/or low IgG3 levels were found in patients with juvenile diabetes mellitus. (5) Mothers giving birth to severely group B streptococci infected infants showed low levels of IgG subclasses indicating that the newborns were IgG subclass deficient at birth. (6) In a prospective study of children with recurrent otitis media aged 12 and 32 months the IgG2 levels were significantly reduced in the group with considerably high otitis proneness. In patients with IgG2-IgG4 deficiency, absence of antibodies to polysaccharide antigen teichoic acid and the protein antigen alpha-toxin of staphylococci was demonstrated. Imbalanced IgG subclass pattern with increased IgG4 was recorded in patients with different diseases such as atopic diseases and also in combination with increased IgE, Henoch-Schönlein vasculitis, idiopathic pulmonary hemosiderosis, chronic mucocutaneous candidiasis, and in patients with Trichuris trichiura infection.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6369977     DOI: 10.1016/0002-9343(84)90314-0

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  31 in total

1.  Incidence of selective IgG2 deficiency in patients with vasculitis.

Authors:  A Jiménez; M López-Trascasa; G Fontán
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

2.  IgG subclass distribution in serum and rectal mucosa of monozygotic twins with or without inflammatory bowel disease.

Authors:  L Helgeland; C Tysk; G Järnerot; K Kett; E Lindberg; D Danielsson; S N Andersen; P Brandtzaeg
Journal:  Gut       Date:  1992-10       Impact factor: 23.059

3.  Immunodeficiency and autoimmune enterocolopathy linked to NFAT5 haploinsufficiency.

Authors:  Brigid S Boland; Christella E Widjaja; Asoka Banno; Bing Zhang; Stephanie H Kim; Samantha Stoven; Michael R Peterson; Marilyn C Jones; H Irene Su; Sheila E Crowe; Jack D Bui; Samuel B Ho; Yoshinaga Okugawa; Ajay Goel; Eric V Marietta; Mahdieh Khosroheidari; Kristen Jepsen; Jose Aramburu; Cristina López-Rodríguez; William J Sandborn; Joseph A Murray; Olivier Harismendy; John T Chang
Journal:  J Immunol       Date:  2015-02-09       Impact factor: 5.422

4.  Cytokine responses of human blood monocytes stimulated with Igs.

Authors:  J L Foreback; D G Remick; E Crockett-Torabi; P A Ward
Journal:  Inflammation       Date:  1997-10       Impact factor: 4.092

5.  Non-infective colitis in infancy: evidence in favour of minor immunodeficiency in its pathogenesis.

Authors:  A Ojuawo; D St Louis; K J Lindley; P J Milla
Journal:  Arch Dis Child       Date:  1997-04       Impact factor: 3.791

Review 6.  Why do viruses make infants wheeze?

Authors:  I M Balfour-Lynn
Journal:  Arch Dis Child       Date:  1996-03       Impact factor: 3.791

7.  Intravenous immune globulins (IVIg) treatment for organizing pneumonia in a selective IgG immune deficiency state.

Authors:  Itai Gueta; Yehuda Shoenfeld; Hedi Orbach
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

Review 8.  Clinical significance of IgG subclass deficiency.

Authors:  G Morgan; R J Levinsky
Journal:  Arch Dis Child       Date:  1988-07       Impact factor: 3.791

9.  IgG abnormality in narcolepsy and idiopathic hypersomnia.

Authors:  Susumu Tanaka; Makoto Honda
Journal:  PLoS One       Date:  2010-03-05       Impact factor: 3.240

10.  Antibody affinity and IgG subclass of responses to tetanus toxoid in patients with rheumatoid arthritis and systemic lupus erythematosus.

Authors:  M E Devey; K Bleasdale; D A Isenberg
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.